Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease
JACC: Advances · 2023-11 · 2 (9) · 100656
DOI: 10.1016/j.jacadv.2023.100656 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Advances, 2023-11. Verfasst von Tsukasa Kato und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Akita University School of Medicine, Akita, Japan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The prevalence and degree of lower extremity artery disease in hemodialysis (HD) patients is higher than in the general population. However, the pathological features have not yet been evaluated.
Objectives
The aim of the study was: 1) to compare lesion characteristics of lower extremity artery disease in HD vs non-HD patients; and 2) to determine factors associated with severe medial calcification.
Methods
Seventy-seven lower limb arteries were assessed from 36 patients (median age 77 years; 23 men; 21 HD and 15 non-HD) who underwent autopsy or lower limb amputation. Arteries were serially cut at 3- to 4-mm intervals creating 2,319 histological sections. Morphometric analysis and calcification measurements were performed using ZEN software. Calcification with a circumferential angle (arc) ≥180° was defined as severe calcification. Multivariable logistic regression was used to identify risk factors for severe medial calcification.
Results
The degree of the medial calcification arc was significantly higher in the HD group compared to the non-HD group (P < 0.0001). In the multivariable analysis, HD was associated with severe medial calcification in below-the-knee lesions (OR: 17.1; P = 0.02). The degree of intimal calcification in above-the-knee lesions was also significantly higher in HD patients with a higher prevalence of advanced atherosclerotic plaque (P = 0.02). The prevalence of severe bone formation was more common in the HD patients (P = 0.01).
Conclusions
Hemodialysis patients demonstrated a higher degree of medial and intimal calcification compared with non-HD patients. The difference was more prominent in the medial calcification of below-the-knee lesions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Akita University School of Medicine, Akita, Japan.
- Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
- Kasukabe Chuo General Hospital, Limb Salvage Center, Kasukabe, Japan.
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan.
- Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
- Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
Zitieren
APA
Kato, T., Torii, S., Nakamura, N., Aihara, K., Terabe, Y., Iida, O., Tokuda, T., Nakama, T., Kawahara, Y., Miyamoto, J., Saito, T., Kamioka, N., Murakami, T., Ijichi, T., Natsumeda, M., Tanaka, S., Ohno, Y., Nakazawa, G., Watanabe, H., & Ikari, Y. (2023). Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease. JACC: Advances, 2(9), 100656. https://doi.org/10.1016/j.jacadv.2023.100656
Vancouver
Kato T, Torii S, Nakamura N, Aihara K, Terabe Y, Iida O, et al. Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease. JACC: Advances. 2023;2(9):100656. doi:10.1016/j.jacadv.2023.100656
BibTeX
@article{Kato2023,
author = {Kato, Tsukasa and Torii, Sho and Nakamura, Norihito and Aihara, Kazuki and Terabe, Yuta and Iida, Osamu and Tokuda, Takahiro and Nakama, Tatsuya and Kawahara, Yo and Miyamoto, Junichi and Saito, Takafumi and Kamioka, Norihiko and Murakami, Tsutomu and Ijichi, Takeshi and Natsumeda, Makoto and Tanaka, Shigemitsu and Ohno, Yohei and Nakazawa, Gaku and Watanabe, Hiroyuki and Ikari, Yuji},
title = {Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease},
journal = {JACC: Advances},
year = {2023},
volume = {2},
number = {9},
pages = {100656},
doi = {10.1016/j.jacadv.2023.100656}
}
EUVIMED